Ki‐Kwang Oh

1.1k total citations · 1 hit paper
52 papers, 728 citations indexed

About

Ki‐Kwang Oh is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Ki‐Kwang Oh has authored 52 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 17 papers in Epidemiology and 16 papers in Pharmacology. Recurrent topics in Ki‐Kwang Oh's work include Liver Disease Diagnosis and Treatment (17 papers), Computational Drug Discovery Methods (15 papers) and Pharmacological Effects of Natural Compounds (13 papers). Ki‐Kwang Oh is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Computational Drug Discovery Methods (15 papers) and Pharmacological Effects of Natural Compounds (13 papers). Ki‐Kwang Oh collaborates with scholars based in South Korea, Bangladesh and Italy. Ki‐Kwang Oh's co-authors include Md. Adnan, Dong Ha Cho, Ki Tae Suk, Sang Jun Yoon, Sung‐Min Won, Satya Priya Sharma, Dong Joon Kim, Haripriya Gupta, Jin‐Ju Jeong and Md. Nazim Uddin Chy and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Ki‐Kwang Oh

51 papers receiving 719 citations

Hit Papers

Gut microbiota-derived indole compounds attenuate metabol... 2024 2026 2025 2024 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation
    2024 69 citations Byeong Hyun Min, Haripriya Gupta et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ki‐Kwang Oh South Korea 16 328 162 161 95 87 52 728
MD. Hasanur Rahman Bangladesh 18 351 1.1× 66 0.4× 152 0.9× 86 0.9× 66 0.8× 51 879
Bader Alshehri Saudi Arabia 18 271 0.8× 72 0.4× 122 0.8× 149 1.6× 43 0.5× 43 818
Jung Chao Taiwan 15 379 1.2× 181 1.1× 123 0.8× 27 0.3× 52 0.6× 28 855
Kozue Sakao Japan 20 574 1.8× 144 0.9× 127 0.8× 27 0.3× 76 0.9× 53 1.1k
Yi-Hang Wu China 19 445 1.4× 179 1.1× 138 0.9× 20 0.2× 51 0.6× 31 1.0k
Alaa Sirwi Saudi Arabia 18 244 0.7× 53 0.3× 83 0.5× 31 0.3× 61 0.7× 34 682
Yan Dai China 14 438 1.3× 278 1.7× 101 0.6× 24 0.3× 109 1.3× 20 1.2k
Iqra Sarfraz Pakistan 14 398 1.2× 91 0.6× 47 0.3× 46 0.5× 39 0.4× 23 816
Raghad Khalid AL-Ishaq Qatar 12 321 1.0× 92 0.6× 50 0.3× 47 0.5× 78 0.9× 16 957
Yu Su Shin South Korea 18 333 1.0× 134 0.8× 61 0.4× 25 0.3× 63 0.7× 40 760

Countries citing papers authored by Ki‐Kwang Oh

Since Specialization
Citations

This map shows the geographic impact of Ki‐Kwang Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ki‐Kwang Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ki‐Kwang Oh more than expected).

Fields of papers citing papers by Ki‐Kwang Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ki‐Kwang Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ki‐Kwang Oh. The network helps show where Ki‐Kwang Oh may publish in the future.

Co-authorship network of co-authors of Ki‐Kwang Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Ki‐Kwang Oh. A scholar is included among the top collaborators of Ki‐Kwang Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ki‐Kwang Oh. Ki‐Kwang Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Jeong Ha, Min Ju Kim, Jung A Eom, et al.. (2025). Synbiotic combination of fructooligosaccharides and probiotics ameliorates the metabolic dysfunction-associated steatotic liver disease. The Journal of Microbiology. 63(2). e2411002–e2411002. 2 indexed citations
2.
3.
Oh, Ki‐Kwang, et al.. (2024). A blueprint of synergistic effect in Ilex Cornuta stems and gut microbiota against Crohn's disease via systems biology concept. Food Bioscience. 62. 105530–105530. 1 indexed citations
4.
Gupta, Haripriya, Raja Ganesan, Satya Priya Sharma, et al.. (2024). New insight of chemical constituents in Persea americana fruit against obesity via integrated pharmacology. Clinical and Translational Science. 17(3). e13778–e13778. 2 indexed citations
5.
Sharma, Satya Priya, Haripriya Gupta, Sangyoon Lee, et al.. (2024). Gut microbiome and metabolome signatures in liver cirrhosis-related complications. Clinical and Molecular Hepatology. 30(4). 845–862. 13 indexed citations
6.
Oh, Ki‐Kwang, et al.. (2024). The unfolded features on the synchronized fashion of gut microbiota and Drynaria rhizome against obesity via integrated pharmacology. Food Chemistry. 460(Pt 2). 140616–140616. 1 indexed citations
7.
Gupta, Haripriya, Raja Ganesan, Satya Priya Sharma, et al.. (2024). A consortium of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via data-driven analysis. Artificial Cells Nanomedicine and Biotechnology. 52(1). 250–260. 2 indexed citations
8.
Oh, Ki‐Kwang, Sang Jun Yoon, Haripriya Gupta, et al.. (2023). The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study. Journal of Translational Medicine. 21(1). 263–263. 6 indexed citations
9.
Oh, Ki‐Kwang, Haripriya Gupta, Byeong Hyun Min, et al.. (2023). The identification of metabolites from gut microbiota in NAFLD via network pharmacology. Scientific Reports. 13(1). 724–724. 14 indexed citations
10.
Lee, Na Young, Ki‐Kwang Oh, Haripriya Gupta, et al.. (2023). Gut Lactobacillus and Probiotics Lactobacillus lactis/rhamnosis Ameliorate Liver Fibrosis in Prevention and Treatment. The Journal of Microbiology. 61(2). 245–257. 10 indexed citations
11.
Ganesan, Raja, Haripriya Gupta, Jin‐Ju Jeong, et al.. (2023). Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease. Hepatology International. 18(2). 486–499. 26 indexed citations
12.
Adnan, Md., Ki‐Kwang Oh, Azamal Husen, et al.. (2022). Microwave-Assisted Synchronous Nanogold Synthesis Reinforced by Kenaf Seed and Decoding Their Biocompatibility and Anticancer Activity. Pharmaceuticals. 15(2). 111–111. 4 indexed citations
13.
Oh, Ki‐Kwang, Ickwon Choi, Haripriya Gupta, et al.. (2022). New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology study. Artificial Cells Nanomedicine and Biotechnology. 51(1). 1–12. 7 indexed citations
14.
15.
16.
Oh, Ki‐Kwang, Md. Adnan, & Dong Ha Cho. (2021). Elucidating Drug-Like Compounds and Potential Mechanisms of Corn Silk (Stigma Maydis) against Obesity: A Network Pharmacology Study. Current Issues in Molecular Biology. 43(3). 1906–1936. 3 indexed citations
17.
Chy, Md. Nazim Uddin, Md. Adnan, Ester Pagano, et al.. (2021). Central and peripheral pain intervention by Ophiorrhiza rugosa leaves: Potential underlying mechanisms and insight into the role of pain modulators. Journal of Ethnopharmacology. 276. 114182–114182. 87 indexed citations
18.
Oh, Ki‐Kwang, Md. Adnan, & Dong Ha Cho. (2021). Network pharmacology approach to decipher signaling pathways associated with target proteins of NSAIDs against COVID-19. Scientific Reports. 11(1). 9606–9606. 32 indexed citations
19.
Oh, Ki‐Kwang, et al.. (2021). A network pharmacology study on main chemical compounds fromHibiscus cannabinusL. leaves. RSC Advances. 11(19). 11062–11082. 17 indexed citations
20.
Oh, Ki‐Kwang, Md. Adnan, & Dong Ha Cho. (2020). Network pharmacology of bioactives from Sorghum bicolor with targets related to diabetes mellitus. PLoS ONE. 15(12). e0240873–e0240873. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by MD. Hasanur Rahman Breakdown of academic impact, for papers by Bader Alshehri Breakdown of academic impact, for papers by Jung Chao Breakdown of academic impact, for papers by Kozue Sakao Breakdown of academic impact, for papers by Yi-Hang Wu Breakdown of academic impact, for papers by Alaa Sirwi Breakdown of academic impact, for papers by Yan Dai Breakdown of academic impact, for papers by Iqra Sarfraz Breakdown of academic impact, for papers by Raghad Khalid AL-Ishaq Breakdown of academic impact, for papers by Yu Su Shin
Rankless by CCL
2026